However, not all patients can access GLP-1s at the same pace
Novo Nordisk is awaiting new approvals for their oral semaglutide products
For instance, research has investigated microneedle arrays loaded with GLP-1 analogues, demonstrating potential for controlled release and therapeutic effect in experimental settings
In the SURPASS-2 study, the three doses of tirzepatide (5, 10, and 15 mg once weekly) were tested with the GLP-1RA semaglutide (1 mg once weekly) as a comparator in patients not optimally controlled on monotherapy with metformin (71)
At Stanford Health Care, our weight loss specialists understand this and work with you to find the most effective treatment options and customize your care
Retatrutide is emerging as a novel peptide-based weight loss medication with a unique triple-action mechanism